The high dose combination vaccine delivered by the i.n. route induced a similar level of CD8+ T cells to the lipopeptide alone and, notably, the low dose combination gave a significantly higher level of CD8+ T cell induction (p<0.01 versus SV10-LP, <0.001 versus PBS), that was comparable to virus infection (p<0.05). Here, CD8A is linked to viral infectious disease.